Merck
Owkin and Merck enter collaboration agreement for AI-powered cancer diagnostics
December 20, 2023Research and Development AI diagnostics, Cancer, MSD, Merck, Oncology, Owkin
Owkin and Merck, known as MSD outside of the US and Canada, have announced that they have entered into a …
Merck and Moderna initiate phase 3 study of NSCLC treatment
December 13, 2023Medical Communications Merck, Moderna, NSCLC, Oncology, clinical trial
Merck (known as MSD outside of the US and Canada) and Moderna have announced the initiation of the phase 3 …
Merck collaborates with Acceleration Consortium for AI experimentation
December 8, 2023Research and Development AI, Acceleration Consortium, Merck, Pharmacy, experimentation
Merck and the Acceleration Consortium have announced their AI-driven experimentation planner Bayesian Back End (BayBE) is now available open-source on …
Merck to acquire Caraway Therapeutics for up to $610m
November 22, 2023Business Services Caraway Therapeutics, MSD, Merck, Pharmacy, acquisition
Merck (known as MSD outside of the US and Canada) and Caraway Therapeutics have announced that they have entered into …
FDA approves Merck’s Keytruda for gastric cancer treatment
November 17, 2023Medical Communications FDA, MSD, Merck, Oncology, gastric cancer, keytruda
Merck, known as MSD outside of the US, has announced that the US Food and Drug Administration (FDA) has approved …
Merck’s Keytruda approved by EC for gastric cancer
August 30, 2023Research and Development EC, Merck, Oncology, gastric cancer, keytruda
Merck (known as MSD outside of the US and Canada) has announced the approval of its gastric cancer treatment, Keytruda, …
Lynparza granted approval to treat prostate cancer in Japan
August 25, 2023Research and Development Merck, Oncology, astra zeneca, prostate cancer
AstraZeneca and Merck (known as MSD outside the US and Canada) have received approval from the Japanese Ministry of Health, …
Merck announces phase 3 LITESPARK-005 trial met primary endpoint
August 22, 2023Research and Development Merck, Oncology, Welireg, belzutifan, clinical trial, renal cell carcinoma
Merck (known as MSD outside of the US and Canada) has shared topline results from its phase 3 LITESPARK-005 trial, …
Astex expands collaboration with MSD
August 8, 2023Business Services Astex pharmaceuticals, Merck, Oncology, collaboration, small molecules
Astex Pharmaceuticals has announced an exclusive worldwide research collaboration and license agreement with MSD (known as Merck in the US), …
Merck shares data from phase 3 trial for breast cancer treatment
August 1, 2023Research and Development MSD, Merck, Oncology, breast cancer, keytruda
Merck, also known as MSD outside of the US and Canada, has announced positive results from the phase 3 KEYNOTE-756 …
Merck invests €35m in biosafety testing in Scotland
May 31, 2023Manufacturing and Production Merck, biosafety, drug development, testing
Merck has announced that it has invested €35m in biosafety testing at its sites in Glasgow and Stirling, both Scotland. …
NICE rejects Merck Serono’s Bavencio for urothelial cancer
May 10, 2021Sales and Marketing MSD, Merck, NHS, NICE, cancer treatment, pharma, pharma news
The use of avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy is not recommended by …
Merck kidney and uterus cancer treatments granted priority review by FDA
May 7, 2021Medical Communications FDA, MSD, Merck, cancer treatment, kidney cancer treatment, pharma, pharma news, uterus cancer treatment
The FDA has granted priority review for Merck (MSD) and Eisai’s application for two new approvals for the combination of …
Merck cease development of $425 million COVID-19 treatment
April 16, 2021Medical Communications COVID-19, MSD, Merck, covid-19 treatment, pharma, pharma news
Merck (MSD) have ended the development of their MK-7110 drug for the treatment of hospitalised patients with COVID-19.
Merck and UCLA find new COVID-19 treatment candidate
March 25, 2021COVID-19, Merck, berzosertib, covid-19 treatment, ucla
Merck (MSD in the UK), the UCLA, and other universities from the US and Germany have uncovered a compound that …
